Glycosyltransferase-Mediated Exchange of Rare Microbial Sugars with Natural Products by Ramesh P. Pandey & Jae K. Sohng
OPINION
published: 16 November 2016
doi: 10.3389/fmicb.2016.01849
Frontiers in Microbiology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 1849
Edited by:
Javier González-Sabín,
EntreChem, Spain
Reviewed by:
Shawn Chen,
Revive Genomics Inc., USA
Carlos Olano,
Universidad de Oviedo, Spain
*Correspondence:
Ramesh P. Pandey
pandey@sunmoon.ac.kr
Jae K. Sohng
sohng@sunmoon.ac.kr
Specialty section:
This article was submitted to
Microbiotechnology, Ecotoxicology
and Bioremediation,
a section of the journal
Frontiers in Microbiology
Received: 20 September 2016
Accepted: 03 November 2016
Published: 16 November 2016
Citation:
Pandey RP and Sohng JK (2016)
Glycosyltransferase-Mediated
Exchange of Rare Microbial Sugars
with Natural Products.
Front. Microbiol. 7:1849.
doi: 10.3389/fmicb.2016.01849
Glycosyltransferase-Mediated
Exchange of Rare Microbial Sugars
with Natural Products
Ramesh P. Pandey 1, 2* and Jae K. Sohng 1, 2*
1Department of BT-Convergent Pharmaceutical Engineering, Sun Moon University, Asan-si, South Korea, 2Department of
Life Science and Biochemical Engineering, Sun Moon University, Asan-si, South Korea
Keywords: glycosyltransferase, glycodiversification, glycosylation, natural products, rare microbial sugar
A large number of plant and microbial architectures have been identified and investigated
for potential applications in therapeutics, cosmetics, and nutrition. Nonetheless, continuous
identification, and design of novel lead molecules are prerequisites to tackling emerging diseases
since most existing drugs are losing utility because of resistance by microorganisms. Advances
in biotechnological tools in systems and synthetic biology, chemical biology and metabolic
engineering, genome sequencing, and synthesis, protein engineering andmutagenesis have enabled
alteration of the biological routes of natural product (NP) biosynthesis in heterologous robust hosts
to produce a wide array of compounds (Pandey et al., 2016), thus adding diversity in the NPs.
Post-modifications of NPs by tailoring enzymes is one of the promising approaches for engineering
and manipulating NPs under human control with selective power. Glycosyltransferases (GTs) have
been attracting tremendous attention because of their potential to diversify NPs by conjugating
diverse types of sugar appendages (Williams et al., 2007, 2011; Pandey et al., 2014), and altering
the physico-chemical and biological properties, such as adsorption, distribution, metabolism, and
excretion of molecules (Weymouth-Wilson, 1997). For example, when mycosamine sugar was
replaced by perosamine in amphotericin B, antifungal and hemolytic activities were improved
in new derivative which has minimal inhibitory activity concentration (MIC) of 1.9 µg/ml
compared to 2.1 µg/ml of amphotericin B against Saccharomyces cerevisiae (Hutchinson et al.,
2010). Similarly, when D-desosamine of YC-17 was replaced with four sugars D-quinovose,
L-rhamnose, L-olivose, and D-boivinose, the L-rhamnose sugar conjugated derivative exhibited
better antibacterial activity than the parent YC-17 against erythromycin-susceptible and resistant
Enterococcus faecium and Staphylococcus aureus (Shinde et al., 2013). GTs have also been exploited
to reverse the glycosylation reactions in NPs (Zhang et al., 2006). This property of GTs expanded
the possibility of synthesizing diverse nucleotide diphosphate (NDP)-sugars and exchanging them
among different classes of NPs by single vessel trans-glycosylation (Zhang et al., 2014).
The application of GTs in the industrial biosynthesis of NP glycosides (De Bruyn et al., 2015),
detoxification of pollutants, pesticides, and xenobiotics (Stupp et al., 2013), and homeostasis of
plant hormones to control crop engineering (Tiwari et al., 2016) has profound impact on human
daily life. Thus, plant and microbial GTs with broad substrate promiscuity have been identified
and characterized to glycodiversify NPs to further widen their scope for the generation of future
molecules for human use (Elshahawi et al., 2015; Tiwari et al., 2016). Such powerful enzymes can
be engaged for the exchange of diverse sugar moieties using microbial cells engineered to produce
secondary metabolites using metabolic engineering tools.
Most of the plant glycosylated secondary metabolites contain unmodified simple sugars, such
as D-glucose, D-galactose, D-glucuronic acid, L-rhamnose, D-xylose, and D-arabinose and many
more. Thus, plant GTs are usually studied for their catalytic potential to harness the aforementioned
simple sugar moieties for a diverse class of metabolites, such as polyphenols, terpenoids, benzoates,
salicyclic acids, and polyketides. In contrast to plant glycosides, microbial originated glycosylated
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molecules contain highly modified deoxysugars with different
functional moieties, such as amino-, nitro-, keto-, and sulfo-
groups in their structures. These modified sugar moieties
are found to play a crucial role in executing biological
functions to those microbial metabolites, such as doxorubicin,
staurosporine, vancomycin, calicheamicin, amphotericin B,
tylosin, and erythromycin (Kren and Rezanka, 2008).
GT-mediated exchange of sugar moieties of microbial origin
with secondary metabolites in metabolically engineered hosts
is a fascinating viable approach for the generation of novel
biologically potent compounds (Chen, 2011). This approach
can be achieved in two different ways as shown in Figure 1.
The first approach is to supplement aglycone along with
a chemically modified synthesized sugar in an engineered
microbial cell harboring anomeric kinase (AK), nucleotidyl
transferase (NT), and a promiscuous GT. All three enzymes
should be capable of harnessing diverse sets of sugars, sugar
phosphates, and NDP-sugars, respectively. AK phosphorylates
exogenously supplemented sugar to sugar-1-phosphate, which
is subsequently utilized by NT to produce NDP-sugar at an
expense of NTP. Thus, the generated NDP-sugar is utilized by
GT as a donor substrate and the sugar moiety is transferred
to exogenously supplemented aglycone/acceptor molecules. The
newly generated glycosides are usually excreted outside of the cell
into the culture medium and are readily extracted and purified.
In contrast to the first approach, the second in vivo glycosylation
platform does not require the supplementation of chemically
synthesized sugars. Nevertheless, rare NDP-sugars are produced
in the cell cytosol by heterologous expression of diverse sets
of sugar cassettes. These rare sugars are finally transferred to
exogenously supplemented aglycones by substrate promiscuous
GT. The production of diverse NDP-sugars in the cell cytosol by
both approaches glycodiversify the exogenously added molecule.
Such green approaches for the in vivo glycodiversification of
aglycones by diverse sugar appendages are superior to existing
in vitro strategies. The necessity of multiple enzyme production
and purification for enzymatic synthesis of NDP-sugars, low yield
of purified target NDP-sugars, cofactor addition or regeneration
during the process of reaction usually increases the process
cost for in vitro glycorandomization (Fu et al., 2004). On the
other hand, the chemical approach for NP glycosides synthesis
is tedious, hazardous, time consuming, and requires protection
and de-protection of the functional groups. Since there is a high
chance of by-products formation, the purification of molecules
is difficult, which ultimately lowers the production yield of the
target molecule. Thus, the microbial approach of conjugating
diverse sugars to aglycones is the simplest, cheapest, and easiest
approach that can be readily scaled up to industrial level
by simply fermenting engineered microbes and supplementing
aglycones and sugars as required (Song et al., 2013). However,
in vivo glycorandomization approach needs further development
because some of the aglycone substrates fed to the microbial
culture system require specific transporters for entry and
exit of the substrates and products through the membrane,
respectively. This problem of substrate transportation could be
addressed by overexpression of specific transporter proteins to
the host organisms. Additionally, endogenous NDP-sugars or
free monosaccharides (first approach Figure 1) compete with
target unnatural sugar that has to be transferred to aglycone
during in vivo glycosylation reaction. Rewiring of endogenous
sugar pathways in host cell by metabolic engineering could
overcome this problem of substrates competition in the cell
cytosol.
Simple and high-throughput screening methods are
prerequisite to identify sugar-exchanged products and to
access the activities of engineered GTs in glycosylation reactions.
However, very few such analytical methods are developed to
detect glycosylated products at relatively low concentration.
Some of the high-throughput methods used in glycosylation
reactions are (i) use of fluorescent compounds as acceptor
substrates whose fluorescence signal decreases upon sugar
conjugation (Gantt et al., 2008), (ii) fluorescence-activated cell
sorting (FACS) analysis used to identify cells in which fluorescent
labeled sugars conjugated molecules are entrapped (Yang et al.,
2010), (iii) enzyme-linked immunosorbent assay (ELISA) based
detection of glycosylated products using carbohydrate-binding
proteins (Hancock et al., 2009), and (iv) pH based color change
of indicator molecule in the course of glycosylation reaction
(Park et al., 2009). Besides these methods, the most abundantly
used analytical approach for glycosylation reactions is high-
performance liquid chromatography (HPLC). HPLC could be
coupled with high resolution mass spectrometry (HR/MS) for
direct identification of the NP-glycosides. HPLC based analyses
of glycosylation reactions are not applicable for high-throughput
screening of large number of GTs and their mutants. Hence,
the development of a more efficient high-throughput screening
approach for GT-mediated glycosylation reactions is obligatory.
Recently, advances have been made in the construction of
robust microbial cells for the synthesis of several biomolecules
in E. coli, S. cerevisiae, and Streptomyces. These biosynthesis
approaches include de novo pathway engineering, central carbon
flux redirection for co-factor or precursor synthesis, the selection
of alternative enzymes, protein engineering/mutagenesis,
precursor directed mutasynthesis, modular metabolic
engineering, system and synthetic biology tools, such as
codon optimization, vector, promoter, ribosome binding
site engineering, and the engineering and manipulation of
other non-protein-coding sequences (Pandey et al., 2016). For
microbial production of NP glycosides, though different enzymes
sources, particularly GTs, are used, no system/synthetic biology
tools are applied for co-factor regeneration in microbial cell
cytosol. Flux analysis for co-factor regeneration and optimum
cell growth maintenance is crucial for efficient biosynthesis
of glycosides. Several pathway genes for rare NDP-sugars,
particularly thymidine diphosphate (TDP)-sugars, can be
heterologously expressed for the modification of TDP-4-keto-
6-deoxy-D-glucose (TKDG), which is the major intermediate
of TDP-deoxysugars (Thibodeaux et al., 2008). Fine tuning of
all possible heterologously expressed genes is essential for the
balanced production of final NDP-sugars. In most cases for the
biosynthesis of non-natural glycosides, the major limiting factor
is the production of NDP-sugar in the cell cytosol of E. coli. This
hurdle can be addressed by regulating intermediate consuming
pathway genes in the chromosome of host organisms. Several
Frontiers in Microbiology | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1849
Pandey and Sohng Glycosyltransferse-Mediated Natural Products Modification
FIGURE 1 | GT-mediated microbial glycone and aglycone exchange platforms for NPs diversification by glycosylation (X = O, S, or NH). In first strain,
reducing sugars and aglycones are fed while in second strain only aglycones are fed. AK, anomeric kinase; NT, nucleotidyl transferase; GT, glycosyltransferase.
studies have been reported by our group (Malla et al., 2013;
Pandey et al., 2015) and other researchers to block alternate
biosynthesis pathway genes in E. coli by constructing background
E. colimutants (Kim et al., 2015). However, the complete knock-
down of essential genes for cell wall biosynthesis hampers cell
growth and necessitates additional precursors to supplement
the intermediates of blocked pathways. Thus, to rule out these
problems, we should apply recently developed gene regulation
tools, such as clustered regularly interspaced short palindromic
repeats interference (CRISPERi) (Larson et al., 2013) and sRNA
mediated gene regulation systems (Yoo et al., 2013) to control
the flow of NDP-sugar biosynthesis intermediates to undesired
products without hampering cell health. Moreover, application
of these tools can also maintain high cell density during
fermentation. Beside these options, the adequate expression of
heterologous genes in the engineered host is another important
aspect for rare NDP-sugar biosynthesis. To balance the fine
tuning of all gene expression, modular and multivariate NDP-
sugar biosynthesis pathways should be constructed to address the
accumulation of an intermediate NDP-sugar in the biosynthesis
pathway. Besides the biosynthesis of rare NDP-sugars in the
microbial cell cytosol, we also need to focus on GT engineering
for the generation of promiscuous GT that can accept diverse
sets of NDP-sugars and acceptors for forward glycosylation
reactions. Only a few GTs have been studied in detail for broad
applications to NP glycodiversification. This is limited because
of the lack of sufficient GTs with crystal structures. Thus, further
study should be focused on the screening of highly promiscuous
GTs and their design/engineering based on crystal structure and
computer based modeling approaches, saturation mutagenesis
after identification of “hot spots” for directed evolution. Such
engineered mutant GTs would have high potential to generate
a wide array of glycodiversified NPs. Eventually upon the
biosynthesis of a library of novel NP glycosides, those molecules
could be accessed for possible applications in therapeutics,
cosmetics, and nutraceutics.
The in vivo fermentation approach for producing NP
glycosides is inadequate for producing a significant amount
of glycosides by simple fermentation even though the process
can be easily subjected to industrial scale up. To produce
future NP glycosides by fermentation, a robust system should
be developed that is capable of producing diverse NDP-sugars
in the cell cytosol while engineering promiscuous GTs for
sugar transfer to acceptor molecules. High level production
of target non-natural NP glycosides can be achieved by
simple microbial fermentation upon proper implementation
of recently developed system/synthetic biology tools for the
engineering of microbial host cells. Cumulatively, this approach
of GT-mediated exchange of microbial non-natural glycones
with exogenous aglycones offers huge combinatorial potential
for the biosynthesis of novel future molecules for human
use.
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